Synopsys Stock Forecast, Price & News

Synopsys (NASDAQ:SNPS) Frequently Asked Questions

Is Synopsys a buy right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last year. There are currently 1 sell rating, 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Synopsys stock.
View analyst ratings for Synopsys or view top-rated stocks.

How has Synopsys' stock price been impacted by Coronavirus?

Synopsys' stock was trading at $131.74 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SNPS stock has increased by 166.2% and is now trading at $350.69.
View which stocks have been most impacted by COVID-19.

When is Synopsys' next earnings date?

Synopsys is scheduled to release its next quarterly earnings announcement on Wednesday, December 1st 2021.
View our earnings forecast for Synopsys.

How can I listen to Synopsys' earnings call?

Synopsys will be holding an earnings conference call on Wednesday, December 1st at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 402-970-0847 with passcode "6504511".

How were Synopsys' earnings last quarter?

Synopsys, Inc. (NASDAQ:SNPS) released its quarterly earnings results on Tuesday, August, 17th. The semiconductor company reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.78 by $0.03. The semiconductor company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. Synopsys had a trailing twelve-month return on equity of 15.03% and a net margin of 18.48%. Synopsys's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.74 earnings per share.
View Synopsys' earnings history.

How will Synopsys' stock buyback program work?

Synopsys declared that its Board of Directors has initiated a stock buyback program on Thursday, June 17th 2021, which permits the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 1.2% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's leadership believes its stock is undervalued.

What guidance has Synopsys issued on next quarter's earnings?

Synopsys updated its FY 2021 earnings guidance on Wednesday, September, 15th. The company provided earnings per share (EPS) guidance of $6.780-$6.830 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.480. The company issued revenue guidance of $4.19 billion-$4.22 billion, compared to the consensus revenue estimate of $4.08 billion.

What price target have analysts set for SNPS?

13 brokers have issued 1 year price targets for Synopsys' stock. Their forecasts range from $315.00 to $400.00. On average, they anticipate Synopsys' stock price to reach $346.91 in the next year. This suggests that the stock has a possible downside of 1.1%.
View analysts' price targets for Synopsys or view top-rated stocks among Wall Street analysts.

Who are Synopsys' key executives?

Synopsys' management team includes the following people:

• Aart J. de Geus, Chairman & Co-Chief Executive Officer
• Chi-Foon Chan, President, Co-Chief Executive Officer & Director
• Sassine Ghazi, Chief Operating Officer
• Trac Pham, Chief Financial Officer (LinkedIn Profile)
• Sriram Sitaraman, Chief Information Officer

What is Dr. Aart J. de Geus and Dr. Chi-Foon Chan's approval rating as Synopsys' CEO?

1,170 employees have rated Synopsys CEO Dr. Aart J. de Geus and Dr. Chi-Foon Chan on Glassdoor.com. Dr. Aart J. de Geus and Dr. Chi-Foon Chan has an approval rating of 95% among Synopsys' employees. This puts Dr. Aart J. de Geus and Dr. Chi-Foon Chan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Synopsys' key competitors?

Some companies that are related to Synopsys include Adobe (ADBE), salesforce.com (CRM), Intuit (INTU), Workday (WDAY), Autodesk (ADSK), Cadence Design Systems (CDNS), ANSYS (ANSS), Tyler Technologies (TYL), SS&C Technologies (SSNC), Splunk (SPLK), Nuance Communications (NUAN), FactSet Research Systems (FDS), Citrix Systems (CTXS), Manhattan Associates (MANH) and Guidewire Software (GWRE).
View all of SNPS's competitors.

What other stocks do shareholders of Synopsys own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synopsys investors own include NVIDIA (NVDA), PayPal (PYPL), Alibaba Group (BABA), Square (SQ), salesforce.com (CRM), Advanced Micro Devices (AMD), Adobe (ADBE), Tesla (TSLA), Netflix (NFLX) and Micron Technology (MU).

What is Synopsys' stock symbol?

Synopsys trades on the NASDAQ under the ticker symbol "SNPS."

Who are Synopsys' major shareholders?

Synopsys' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.35%), Franklin Resources Inc. (2.40%), Geode Capital Management LLC (1.98%), Nordea Investment Management AB (1.77%), Invesco Ltd. (1.75%) and Massachusetts Financial Services Co. MA (1.29%). Company insiders that own Synopsys stock include Bruce R Chizen, Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, Janice Chaffin, John F Runkel Jr, Joseph W Logan, Mercedes Johnson, Roy Vallee, Sassine Ghazi, Steven Walske, Sudhindra Kankanwadi and Trac Pham.
View institutional ownership trends for Synopsys.

Which institutional investors are selling Synopsys stock?

SNPS stock was sold by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Assenagon Asset Management S.A., Vontobel Asset Management Inc., Arrowstreet Capital Limited Partnership, Janus Henderson Group PLC, Franklin Resources Inc., Millennium Management LLC, and Epoch Investment Partners Inc.. Company insiders that have sold Synopsys company stock in the last year include Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, Janice Chaffin, John F Runkel Jr, Joseph W Logan, Roy Vallee, Sassine Ghazi, Steven Walske, Sudhindra Kankanwadi, and Trac Pham.
View insider buying and selling activity for Synopsys or view top insider-selling stocks.

Which institutional investors are buying Synopsys stock?

SNPS stock was purchased by a variety of institutional investors in the last quarter, including Nordea Investment Management AB, Ownership Capital B.V., Van ECK Associates Corp, Goldman Sachs Group Inc., Two Sigma Advisers LP, ANTIPODES PARTNERS Ltd, Renaissance Technologies LLC, and AXA S.A..
View insider buying and selling activity for Synopsys or or view top insider-buying stocks.

How do I buy shares of Synopsys?

Shares of SNPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Synopsys' stock price today?

One share of SNPS stock can currently be purchased for approximately $350.69.

How much money does Synopsys make?

Synopsys has a market capitalization of $53.48 billion and generates $3.69 billion in revenue each year. The semiconductor company earns $664.35 million in net income (profit) each year or $4.80 on an earnings per share basis.

How many employees does Synopsys have?

Synopsys employs 15,036 workers across the globe.

Does Synopsys have any subsidiaries?

The following companies are subsidiares of Synopsys: Accelerant Networks, Advanced Test Technology Inc., Analog Design Automation, Arcad SA, ArchPro Design Automation, Avant! Corp., Black Duck Software, Black Duck Software Inc., Cadis GmbH, Cascade Semiconductor Solutions, Chipidea Microelectrónica, Cigital, CiraNova, Co-Design Automation, CoWare, Codenomicon, Codiscope, Compiled Designs GmbH, Conversant Intellectual Property Management, Coverity, Coverity LLC, EPIC Design Technology, Elliptic Technologies, Emulation and Verification Engineering, Everest Design Automation, ExperTest, ExpertIO, Extreme DA, Forcheck, Gambit Automated Design, Gemini Design Technology, Goanna Software, Gold Standard Simulations, HPL Technologies Inc., InnoLogic Systems, Integrated Systems Engineering, Kilopass Technology, LEDA Systems, Leda SA, Logic Modeling Corporation, Magma Design Automation, MoSys Inc., Monterey Design Systems, Moortec Semiconductor, Nassda, Nihon Synopsys G.K., Numerical Technologies Inc., Nusym Technology, Optical Research Associates, PhoeniX Software, Pro Design Electronic - CHIPit, Progressant Technologies, Protecode, QTronic GmbH, QuantumWise, RSoft Design Group, Radiant Design Tools, SIGMA-C Software AG, SNPS Ireland New Limited, Sandwork Design Inc., Sidense, Silicon Architects, Simpleware, Smartech Oy, SpringSoft, Stanza Systems, Synfora, Synopsys (India) Private Limited, Synopsys Emulation and Verification S.A.S., Synopsys Global Kft., Synopsys International Limited, Synopsys International Old Unlimited Company, Synopsys International Services Inc., Synopsys Ireland New Limited, Synopsys Ireland Unlimited Company, Synopsys Korea Inc., Synopsys Netherlands B.V., Synopsys Taiwan Co. Ltd., Synopsys Technologies Company Limited, Synopsys Technologies Holding LLC, Synopsys USIE Holdings LLC, Synplicity Inc, Systems Science, Target Compiler Technologies, Terrain EDA, Tinfoil Security, TriCN Associates, VaST Systems Technology, Viewlogic Systems, Virage Logic Corporation, Virtio, WinterLogic, ZEROSOFT, inSilicon Corp., and nSys Design Systems.

When was Synopsys founded?

Synopsys was founded in 1986.

What is Synopsys' official website?

The official website for Synopsys is www.synopsys.com.

Where are Synopsys' headquarters?

Synopsys is headquartered at 690 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043.

How can I contact Synopsys?

Synopsys' mailing address is 690 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The semiconductor company can be reached via phone at (650) 584-5000, via email at [email protected], or via fax at 650-965-8637.